'Sundowning' behaviors are linked to neurological basis

'Sundowning' behaviors are linked to neurological basis
'Sundowning' behaviors are linked to neurological basis
Scientists have new evidence that “sundowning” — late-day anxiety and agitation behaviors exhibited by older institutionalized adults — has a neurological basis, according to a new study.

Sundowning is usually seen in dementia patients and is characterized by symptoms of agitation, anxiety, general activity and delirium prior to going to bed. It can be challenging for caregivers to deal with since patients can become aggressive.

“There have been a few clinical studies documenting sundowning, but until now there hasn't been research in animals to see what's going on in the brain to explain this,” said Tracy Bedrosian, author of the study and doctoral student at The Ohio State University.

Bedrosian and her colleagues say they have observed sundowning behaviors in aged mice in the hours before they would typically sleep. Like humans, they demonstrate more anxiety-related activities and are much more agitated. Mice engineered to have Alzheimer's-like conditions displayed more anxiety before sleep, too.

“Some people have argued that sundowning could be explained just by a buildup of frustration in older people who couldn't communicate their needs over the course of the day, or by other factors,” said the study's co-author, Randy Nelson, Ph.D. “But our findings suggest there is a real phenomenon going on here that has a biological basis.”

More in News

Government agency launches health IT webpage for long-term care providers

Government agency launches health IT webpage for long-term ...

The Office of the National Coordinator for Health Information Technology has unveiled a new webpage with information and resources for long-term and post-acute (LTPAC) providers.

FDA responds to provider pressure, backs off stricter control of fecal transplants ...

Individuals with treatment-resistant Clostridium difficile can undergo fecal transplants after giving informed consent, the Food and Drug Administration recently announced. This is a victory for providers, who pushed back after the FDA recently announced it would tighten regulations around the transplants.

Judge denies Omnicare's 'untimely' motion to disqualify whistleblower in nursing home kickbacks ...

Omnicare has failed to disqualify a whistleblower who alleges the long-term care pharmacy paid kickbacks to nursing homes, ruled a district court judge.